Apple is appealing a trade ban that forced it to remove the blood oxygen sensor from its smartwatches, following a 2023 ITC ruling in favor of Masimo over patent violations. The US Court of Appeals recently heard arguments from both companies, with Apple aiming to reinstate the feature, which is part of its broader health technology strategy.
Explain It To Me Like I’m 5: